| pubmed-article:3493590 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3493590 | lifeskim:mentions | umls-concept:C0026809 | lld:lifeskim |
| pubmed-article:3493590 | lifeskim:mentions | umls-concept:C0025922 | lld:lifeskim |
| pubmed-article:3493590 | lifeskim:mentions | umls-concept:C0080194 | lld:lifeskim |
| pubmed-article:3493590 | lifeskim:mentions | umls-concept:C0034496 | lld:lifeskim |
| pubmed-article:3493590 | lifeskim:mentions | umls-concept:C1519477 | lld:lifeskim |
| pubmed-article:3493590 | lifeskim:mentions | umls-concept:C0441472 | lld:lifeskim |
| pubmed-article:3493590 | lifeskim:mentions | umls-concept:C0681829 | lld:lifeskim |
| pubmed-article:3493590 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:3493590 | pubmed:dateCreated | 1987-4-16 | lld:pubmed |
| pubmed-article:3493590 | pubmed:abstractText | An inactivated unconcentrated rabies vaccine was demonstrated to induce the production of T-killers which in adoptive transfer protect 38-43% of recipients challenged intramuscularly with street rabies virus. The production of T-killers depends on the dose and schedule of the antigen inoculation. T-killers in vivo were strictly specific and manifested their protective effect only in syngeneic but not in allogeneic system. | lld:pubmed |
| pubmed-article:3493590 | pubmed:language | rus | lld:pubmed |
| pubmed-article:3493590 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3493590 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:3493590 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3493590 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3493590 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3493590 | pubmed:issn | 0507-4088 | lld:pubmed |
| pubmed-article:3493590 | pubmed:author | pubmed-author:Barinski?I... | lld:pubmed |
| pubmed-article:3493590 | pubmed:author | pubmed-author:GribenchaS... | lld:pubmed |
| pubmed-article:3493590 | pubmed:author | pubmed-author:KiselevaA SAS | lld:pubmed |
| pubmed-article:3493590 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3493590 | pubmed:volume | 31 | lld:pubmed |
| pubmed-article:3493590 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3493590 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3493590 | pubmed:pagination | 691-5 | lld:pubmed |
| pubmed-article:3493590 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:3493590 | pubmed:meshHeading | pubmed-meshheading:3493590-... | lld:pubmed |
| pubmed-article:3493590 | pubmed:meshHeading | pubmed-meshheading:3493590-... | lld:pubmed |
| pubmed-article:3493590 | pubmed:meshHeading | pubmed-meshheading:3493590-... | lld:pubmed |
| pubmed-article:3493590 | pubmed:meshHeading | pubmed-meshheading:3493590-... | lld:pubmed |
| pubmed-article:3493590 | pubmed:meshHeading | pubmed-meshheading:3493590-... | lld:pubmed |
| pubmed-article:3493590 | pubmed:meshHeading | pubmed-meshheading:3493590-... | lld:pubmed |
| pubmed-article:3493590 | pubmed:meshHeading | pubmed-meshheading:3493590-... | lld:pubmed |
| pubmed-article:3493590 | pubmed:meshHeading | pubmed-meshheading:3493590-... | lld:pubmed |
| pubmed-article:3493590 | pubmed:meshHeading | pubmed-meshheading:3493590-... | lld:pubmed |
| pubmed-article:3493590 | pubmed:meshHeading | pubmed-meshheading:3493590-... | lld:pubmed |
| pubmed-article:3493590 | pubmed:meshHeading | pubmed-meshheading:3493590-... | lld:pubmed |
| pubmed-article:3493590 | pubmed:articleTitle | [In vivo study of the protective action of the splenocytes from CBA strain mice immunized with an inactivated nonconcentrated rabies vaccine]. | lld:pubmed |
| pubmed-article:3493590 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:3493590 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:3493590 | pubmed:publicationType | English Abstract | lld:pubmed |
